Sanuwave Health Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Sanuwave Health Inc 's ROA in the second quarter of 2026?
Sanuwave Health Inc achieved a return on average assets (ROA) of 39.64 % in its second quarter of 2026, this is above SNWV's average return on assets of -297.15%.
Sanuwave Health Inc assets over the 12 months ending in its second quarter of 2026 are valued at $36 million

ROA fell compared to the first quarter of 2026, despite the net income growth of % from the first quarter of 2026.

However, within the Healthcare sector 13 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 47, from total ROA ranking in the first quarter of 2026 at 69.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	13 %	19.98 %	22.69 %	61 %	54.16 %
Y / Y Net Income Change	-	-	-67.15 %	-	-91.6 %
Net Income (TTM) in million	14	15	11	23	-8
Return On Assets (TTM)	39.64 %	42.41 %	31.71 %	72.5 %	-26.89 %
SNWV's Total Ranking	# 47	# 69	# 49	# 3717	# 3169
Total Assets (TTM) in million	37	36	37	35	32
Seq. Total Assets Change	1.38 %	-2.29 %	5.08 %	8.57 %	7.64 %
Seq. Net Income Change	-	-	-36.94 %	1658.26 %	-

SNWV's 5 Years Annual ROA >> Back to SNWV Management Effectiveness >> Compare SNWV ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 3
Sector	# 14
Overall	# 47

Return On Assets Statistics
High	Average	Low
74.94 %	-297.15 %	-1290.59 %
(Mar 31 2026)		(Mar 31 2018)

Financial Statements
Sanuwave Health Inc 's Assets	$ 37 million	SNWV's Balance sheet
Sanuwave Health Inc 's Income	$ 0 million	Quarterly SNWV's Income Statement
SNWV's Income by Division		See SNWV's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	22.69 %	34.36 %	12.8 %	6.74 %	-19.14 %
Total Assets in million	37	30	22	20	19
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	24	0	0	0	0
Annual Return On Assets	64.17 %	-0.09 %	-0.02 %	-0.01 %	-0.15 %

SNWV's 5 Years Annual ROA >> Back to SNWV Management Effectiveness >> Compare SNWV ROA to its Competitors

Comment on SNWV's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 64.17 % compared to prior year, due to annual net income growth of % to $23.71 million, while value of Sanuwave Health Inc 's overall assets grew just by 22.69 % to $36.95 million, compared to $36.95 a year before.

More Return On Assets Ratios
SNWV's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SNWV's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SNWV's Competitors
Subscribers only: Roa for Sanuwave Health Inc 's Suppliers
Subscribers only: Return On Assets for SNWV's Customers

You may also want to know
SNWV's Roi	SNWV's Inventory Turnover Ratio	SNWV's Growth Rates	SNWV's Dividend Comparisons
	SNWV's Profitability Ratios	SNWV's Asset Turnover Ratio	SNWV's Dividend Growth
SNWV's Roe	SNWV's Valuation Ratios	SNWV's Financial Strength Ratios	SNWV's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Elutia Inc	108.72 %
Silexion Therapeutics Corp	99.09 %
Arbutus Biopharma Corp	96.04 %
Pulmatrix Inc	94.81 %
Quince Therapeutics Inc	88.46 %
Interpace Biosciences Inc	85.91 %
Oncotelic Therapeutics Inc	81.75 %
Rigel Pharmaceuticals Inc	72.27 %
Actinium Pharmaceuticals Inc	71.73 %
Sanuwave Health Inc	71.60 %
Exelixis Inc	70.51 %
Rallybio Corporation	64.51 %
Oramed Pharmaceuticals Inc	64.18 %
Fortress Biotech Inc	60.88 %
Atlantic Coastal Acquisition Corp Ii	54.09 %
Lensar Inc	47.48 %
Elite Pharmaceuticals Inc	46.11 %
Omeros Corporation	46.05 %
Q32 Bio Inc	45.18 %
Aurinia Pharmaceuticals Inc	44.95 %
Agenus Inc	44.86 %
Earth Science Tech Inc	44.02 %
Liquidia Corporation	36.30 %
Ironwood Pharmaceuticals inc	34.34 %
Idexx Laboratories Inc	33.61 %
Tg Therapeutics Inc	33.59 %
Meiragtx Holdings Plc	29.37 %
Indivior Pharmaceuticals Inc	28.21 %
Qhslab Inc	27.12 %
Adma Biologics Inc	26.58 %

Date modified: 2026-09-05T15:32:09+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.